Literature DB >> 2019761

Immunity to onchocerciasis: recognition of larval antigens by humans putatively immune to Onchocerca volvulus infection.

T B Nutman1, C Steel, D J Ward, G Zea-Flores, E A Ottesen.   

Abstract

Immunoblot analyses were done using sera from 12 individuals without evidence of onchocerciasis and 16 with active infection from an area of Guatemala holoendemic for onchocerciasis. For adult antigens from Onchocerca volvulus, no differences in antigen recognition could be identified between the two groups. In contrast, when infective larval (L3) antigen preparations derived from the related animal parasite Onchocerca lienalis were used, IgG from the "immune" individuals preferentially recognized a 45- to 50-kDa triplet and a 22-kDa L3 antigen. When L3 antigens of Brugia malayi were used, sera from putatively immune individuals identified a high-molecular-weight triplet/quadruplet plus several additional antigens of lower molecular weights that were recognized by sera from few (or none) of the infected patients. These findings define some differences in antibody specificity in onchocerciasis patients and therefore might define potential target antigens of humoral host defense. The exact nature of such defenses is unknown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019761     DOI: 10.1093/infdis/163.5.1128

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.

Authors:  P T Soboslay; S M Geiger; N Weiss; M Banla; C G Lüder; C M Dreweck; E Batchassi; B A Boatin; A Stadler; H Schulz-Key
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

2.  Calgranulin C has filariacidal and filariastatic activity.

Authors:  J D Gottsch; S W Eisinger; S H Liu; A L Scott
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

3.  The novel cuticular collagen Ovcol-1 of Onchocerca volvulus is preferentially recognized by immunoglobulin G3 from putatively immune individuals.

Authors:  G R Stewart; Y Zhu; W Parredes; T I Tree; R Guderian; J E Bradley
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

4.  In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.

Authors:  Virginia L Tchakouté; Simon P Graham; Siv Aina Jensen; Benjamin L Makepeace; Charles K Nfon; Leo M Njongmeta; Sara Lustigman; Peter A Enyong; Vincent N Tanya; Albert E Bianco; Alexander J Trees
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

5.  Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.

Authors:  P T Soboslay; C G Lüder; W H Hoffmann; I Michaelis; G Helling; C Heuschkel; C M Dreweck; C H Blanke; S Pritze; M Banla
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

6.  Onchocerca volvulus larval antigen, OvB20, induces partial protection in a rodent model of onchocerciasis.

Authors:  M J Taylor; N Abdel-Wahab; Y Wu; R E Jenkins; A E Bianco
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  Individual exposure to Simulium bites and intensity of Onchocerca volvulus infection.

Authors:  C A Jacobi; P Enyong; A Renz
Journal:  Parasit Vectors       Date:  2010-06-18       Impact factor: 3.876

8.  Molecular characterization of a Brugia malayi transglutaminase.

Authors:  Eswaran Devarajan; Pankaj Kumar Mishra; Shiva Thirugnanam; Kapil Mehta; Ramaswamy Chandrashekar; Kaliraj Perumal
Journal:  Parasitol Res       Date:  2004-05-01       Impact factor: 2.289

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.